Cargando…
The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
The most common primary central nervous system tumor in adults is glioblastoma multiforme (GBM). The high invasiveness of GBM cells is an important factor leading to inevitable tumor recurrence and a poor prognosis of patients. GNE-477, a novel PI3K/mTOR inhibitor, has been reported to exert antipro...
Autores principales: | Wang, Yixuan, Shen, Heng, Sun, Qian, Zhao, Linyao, Liu, Hao, Ye, Liguo, Xu, Yang, Cai, Jiayang, Li, Yuntao, Gao, Lun, Tan, Yinqiu, Liu, Baohui, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350478/ https://www.ncbi.nlm.nih.gov/pubmed/34381355 http://dx.doi.org/10.3389/fphar.2021.659511 |
Ejemplares similares
-
PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo
por: Ye, Xueting, et al.
Publicado: (2020) -
Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma
por: Li, Yong, et al.
Publicado: (2022) -
BIRB796, an Inhibitor of p38 Mitogen-Activated Protein
Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
por: Zhao, Linyao, et al.
Publicado: (2021) -
AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
por: Gao, Lun, et al.
Publicado: (2020) -
Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
por: Wu, Xianbo, et al.
Publicado: (2022)